Skip to main content
Premium Trial:

Request an Annual Quote

Temis Acquires i3 Analytics

NEW YORK (GenomeWeb News) – Temis, a semantic solutions provider, has acquired i3 Analytics, a developer of data analytics and visualization technologies for the life sciences, for an undisclosed amount.

According to Temis, the acquisition adds a complementary solution to its existing product portfolio and brings in additional technical know-how to the company that should help expand its life sciences footprint.

I3 Analytics markets Biopharma Navigator, a software-as-a-service platform that provides users with tools to explore and visualize the biopharmaceutical landscape. It gives users access to information that helps them make informed clinical, regulatory, and business decisions.

Temis intends to integrate Biopharma Navigator into Luxid, its flagship platform for identifying and extracting information used to semantically enrich customers' content, and make it available for a variety of applications.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.